Come up with a name for your new list and we'll add to it:
COARE Biotechnology raised a round of funding on August 28, 2013. Investors include
National Institutes of Health.
COARE Biotechnology is focused on targeting tumor-initiating cells in solid tumor cancers. The company utilizes markers of tissue stem/progenitor cells as therapeutic targets. Utilizing tumor xenograf…